Observational study on integrative medical care for chronic illnesses and mental health
AIMS Medical Outcomes Study
This study is testing how a team approach to integrative medical care can help adults and children with chronic illnesses and mental health issues feel better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | Advanced Integrative Medical Science Institute Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT04512755 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effects of advanced integrative specialty medical care on adult and pediatric patients suffering from chronic or serious illnesses and mental health disorders. Conducted at the AIMS Institute, the study employs a team-based approach that includes naturopathy, palliative care, psychiatry, and other specialties, with a focus on coordinated care. Patients will be assessed for health-related quality of life outcomes, and a chart audit will be performed to gather baseline data before enrollment. The study seeks to expand the reach of integrative care to more patients in need.
Who should consider this trial
Good fit: Ideal candidates include new or established patients at the AIMS Institute who are over 18 or have parental consent if under 18.
Not a fit: Patients who cannot read or understand English or are unwilling to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for patients with chronic illnesses and mental health issues through integrative medical approaches.
How similar studies have performed: Other studies have shown promise in using integrative approaches for chronic conditions, but this specific methodology is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients enrolled in the study will meet the following criteria: 1. A new patient coming in for a first office call (FOC) or first consultation via telemedicine with an AIMS physician or advanced practice provider; 2. An established patient; 3. If over 18 years of age are able to understand study design adequately and provide signed informed consent to enrollment; 4. If younger than 18 years of age informed consent from a parent or guardian who is able to understand the study design adequately and provide signed informed consent for the pediatric patient. Exclusion Criteria: * Ineligible participants: 1. Cannot read or understand English well enough to read and sign the consent form and complete the questionnaires; 2. Unwilling to participate in the AIMS Institute observational study.
Where this trial is running
Seattle, Washington
- AIMS Institute — Seattle, Washington, United States (Recruiting)
Study contacts
- Principal investigator: Therry Eparwa, DNP, FNP-BC — AIMS Institute
- Study coordinator: Michelle Speaks, MBA
- Email: mspeaks@aimsinstitute.net
- Phone: 2064201321
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.